Leaning Toward a Better Understanding of CRT in Women
Cardiac resynchronization-defibrillation therapy (CRT-D) is now a well-established treatment for patients with symptomatic heart failure unresponsive to optimized pharmacological therapy, including an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker and a beta-adrenergic block...
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2014-09, Vol.64 (9), p.895-897 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Cardiac resynchronization-defibrillation therapy (CRT-D) is now a well-established treatment for patients with symptomatic heart failure unresponsive to optimized pharmacological therapy, including an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker and a beta-adrenergic blocker (1). [...]as with any observational study, there is a possibility of unmeasured, confounding variables, including noncardiac comorbidities. |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/j.jacc.2014.06.1161 |